0001074140-16-000003.txt : 20160823
0001074140-16-000003.hdr.sgml : 20160823
20160823124305
ACCESSION NUMBER: 0001074140-16-000003
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160810
FILED AS OF DATE: 20160823
DATE AS OF CHANGE: 20160823
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP
CENTRAL INDEX KEY: 0001018735
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
BUSINESS PHONE: 1-800-936-9669
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danielsen Erik
CENTRAL INDEX KEY: 0001682873
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12033
FILM NUMBER: 161846813
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD
CITY: ST LAURENT
STATE: A8
ZIP: H4M 2V2
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2016-08-10
0
0001018735
NYMOX PHARMACEUTICAL CORP
NYMX
0001682873
Danielsen Erik
9900 CAVENDISH BLVD
ST LAURENT
A8
H4M 2V2
QUEBEC, CANADA
0
1
0
0
Chief Financial Officer
Common Stock
9900
D
Erik Danielsen
2016-08-23